No results found for “”
No results found for filter “”
-
Statements & press releases 13.03.24
Yes to EHDS, but not at any cost: EFPIA calls upon the EHDS trilogue negotiators to take sufficient time...
EFPIA reiterates its call to the co-legislators to take sufficient time for critical examination of the EHDS draft regulation or risk compromise on alternative...
Read Article -
Statements & press releases 13.03.24
EFPIA and Vaccines Europe statement on the revision of the EU variations framework
We consider these targeted changes to be encouraging steps towards a more efficient, streamlined framework which may be fully realized after the update...
Read Article -
Blog articles 12.03.24
Reintegrating cancer patients into professional and social life (Guest blog)
People with certain cancers are living longer, fuller lives. We must come together to support their return to work
Read Article -
Blog articles 12.03.24
Healthcare innovation moves fast – so should the European regulatory system (Guest blog)
What will the innovations of tomorrow look like and how can they be regulated effectively without delaying access?
Read Article -
Blog articles 06.03.24
How to Unlock the Power of Drug Repurposing? EFPIA perspective
We propose principles to guide policies and legislations that will ensure safety and efficacy of repurposed drugs.
Read Article -
Blog articles 04.03.24
Make or break: The future of Regulatory Data Protection in Europe
When the Prime Minister of Belgium is calling for an Industrial Deal, when the Commission President has tasked former Italian Prime Minister Draghi to...
Read Article -
Statements & press releases 26.02.24
The draft text of the European Health Data Space (EHDS) in trilogues sparks deep concerns in the European...
The draft text of the European Health Data Space (EHDS) in trilogues sparks deep concerns in the European healthcare ecosystem
Read Article -
Blog articles 26.02.24
Imagining a future where rare diseases patients have a better chance at a healthy life
Past legislation has inspired impressive medicines development in Europe and we must continue to drive progress to deliver new, life-changing therapies...
Read Article -
Blog articles 26.02.24
For healthcare to be sustainable, it must work for innovators, healthcare systems and patients (Guest...
Properly designed policies can reward innovation, drive value and improve patients’ access to medicines.
Read Article -
Statements & press releases 23.02.24
WTO Ministerial Conference in Abu Dhabi an opportunity to strengthen trade and health agenda
A joint statement calling on trade ministers to commit to a comprehensive trade and health agenda that will strengthen the innovation ecosystem, remove...
Read Article -
Blog articles 21.02.24
EU HTA Implementation: Challenges, Commitments and Collective Actions (Guest blog)
There is less than one year to go before EU HTA is either a meaningful contributor to faster access for patients, and the foundation of a stronger and...
Read Article -
EFPIA News 13.02.24
European business calls for deepening the EU Single Market and renewing the dynamic of European integration...
Read the joint statement from 26 trade associations.
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 13.02.24
European business calls for deepening the EU Single Market and renewing the dynamic of European integration...
Read the joint statement from 26 trade associations.
Read Article -
EFPIA News 06.02.24
Recording Now Available: EJP RD-EFPIA Joint Advanced Webinar on Real-World Data, Machine Learning, and...
...
Read Article -
EFPIA News 27.10.23
Stefan Oelrich's interview at the POLITICO Health Care Summit
Watch the recording.
Read Article -
EFPIA News 15.10.23
EFPIA Japan Day 2023
With a delegation from EFPIA in Brussels, EFPIA Japan recently held “EFPIA Day” in Tokyo
Read Article -
EFPIA News 13.07.23
Joint Position Paper on the Hospital Exemption Scheme for ATMPs
Our organisations are committed to engage with policymakers and interested stakeholders for an inclusive and solutions-driven approach on the HE in the...
Read Article -
EFPIA News 13.07.23
Access to oncology combination therapies in Europe: Today's challenges and solutions
Despite the significant value combination therapies bring to cancer care, there are several challenges to their access in Europe. Without action, some...
Read Article -
EFPIA News 12.06.23
IHI Calls 4 and 5: Publication of draft topics and opening of registration to call days
IHI Call Days: Calls 4 & 5
Read Article -
EFPIA News 27.04.23
IHI seeks patients and caregivers to contribute to its activities
IHI is calling on patients and informal caregivers to apply to be part of a new IHI Patient Pool which will strengthen IHI’s ties with the patient community,...
Read Article -
EFPIA News 15.12.22
EFPIA survey among member companies on compliance with the EFPIA-PHRMA principles for responsible clinical...
EFPIA members continue to be committed to responsible clinical trial data sharing, for the benefit of patients and researchers
Read Article -
EFPIA News 13.12.22
IHI launches new funding round
The Innovative Health Initiative (IHI) has launched its third call for proposals, featuring topics covering rare diseases and mental health, and addressing...
Read Article -
EFPIA News 07.11.22
Europe’s share of global medicines R&D shrinks by a quarter in 20 years – as sector’s declining trends...
EFPIA is warning that the options being discussed by policy makers in the context of the EU Pharma Strategy fall well short of addressing concerns and...
Read Article -
EFPIA News 05.10.22
Pharmaceutical industry response to the war in Ukraine
Supporting people affected by the war
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 13.03.24
Yes to EHDS, but not at any cost: EFPIA calls upon the EHDS trilogue negotiators to take sufficient time...
EFPIA reiterates its call to the co-legislators to take sufficient time for critical examination of the EHDS draft regulation or risk compromise on alternative...
Read Article -
Statements & press releases 13.03.24
EFPIA and Vaccines Europe statement on the revision of the EU variations framework
We consider these targeted changes to be encouraging steps towards a more efficient, streamlined framework which may be fully realized after the update...
Read Article -
Statements & press releases 26.02.24
The draft text of the European Health Data Space (EHDS) in trilogues sparks deep concerns in the European...
The draft text of the European Health Data Space (EHDS) in trilogues sparks deep concerns in the European healthcare ecosystem
Read Article -
Statements & press releases 23.02.24
WTO Ministerial Conference in Abu Dhabi an opportunity to strengthen trade and health agenda
A joint statement calling on trade ministers to commit to a comprehensive trade and health agenda that will strengthen the innovation ecosystem, remove...
Read Article -
Statements & press releases 31.01.24
Tackling inequalities: how can Europe beat cancer everywhere?
New study reveals stark differences in spending and patient outcomes across the EU
Read Article -
Statements & press releases 31.01.24
European Health Data Space: key aspects to be considered in the trilogue discussions
EFPIA calls the co-legislators to seize this opportunity to thoroughly examine aspects raised in this paper to provide greater legal certainty and keep...
Read Article -
Statements & press releases 31.01.24
Vaccines Europe and EFPIA advocate for a holistic, data centered approach in Europe's fight against vaccine...
40% of all cancers are preventable and vaccination is a proven preventive measure for both HPV and HBV
Read Article -
Statements & press releases 23.01.24
Cardiovascular disease: LSE-report highlights life-saving potential of secondary prevention
More than 1 million fatal heart attacks & strokes could be prevented with better management of four risk factors
Read Article -
Statements & press releases 23.01.24
EFPIA response to the adoption of the EMA Fees Regulation
EFPIA welcomes the adoption of the EMA Fees regulation by the Council and the Parliament.
Read Article -
Statements & press releases 04.12.23
Stakeholder coalition calls for legislative refinement of the EHDS
Recommendations to facilitate the resolution of five key challenges that will define the impact of the EHDS and its ability to reach the intended policy...
Read Article -
Statements & press releases 03.12.23
Innovative pharmaceutical industry statement on COP28 Declaration on Climate and Health
By IFPMA, ABPI, EFPIA, Farmindustria, Innovative Medicines Canada, JPMA, Leem, PhRMA, vfa
Read Article -
Statements & press releases 01.12.23
EFPIA response to EHDS report adopted by ENVI/LIBE committee in the European Parliament
Sharing a range of electronic health data types for secondary purposes through the EHDS can boost research and innovation, improve treatments and care...
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 12.03.24
Reintegrating cancer patients into professional and social life (Guest blog)
People with certain cancers are living longer, fuller lives. We must come together to support their return to work
Read Article -
Blog articles 12.03.24
Healthcare innovation moves fast – so should the European regulatory system (Guest blog)
What will the innovations of tomorrow look like and how can they be regulated effectively without delaying access?
Read Article -
Blog articles 06.03.24
How to Unlock the Power of Drug Repurposing? EFPIA perspective
We propose principles to guide policies and legislations that will ensure safety and efficacy of repurposed drugs.
Read Article -
Blog articles 04.03.24
Make or break: The future of Regulatory Data Protection in Europe
When the Prime Minister of Belgium is calling for an Industrial Deal, when the Commission President has tasked former Italian Prime Minister Draghi to...
Read Article -
Blog articles 26.02.24
Imagining a future where rare diseases patients have a better chance at a healthy life
Past legislation has inspired impressive medicines development in Europe and we must continue to drive progress to deliver new, life-changing therapies...
Read Article -
Blog articles 26.02.24
For healthcare to be sustainable, it must work for innovators, healthcare systems and patients (Guest...
Properly designed policies can reward innovation, drive value and improve patients’ access to medicines.
Read Article -
Blog articles 21.02.24
EU HTA Implementation: Challenges, Commitments and Collective Actions (Guest blog)
There is less than one year to go before EU HTA is either a meaningful contributor to faster access for patients, and the foundation of a stronger and...
Read Article -
Blog articles 07.02.24
2024: The year to take European action on diabetes to the next level (Guest blog)
Take a stand for the diabetes community
Read Article -
Blog articles 06.02.24
Patient engagement: accelerating progress in a spirit of partnership
Training, sharing best practices and measuring impact are key to moving patients centre stage, according to a survey of the EFPIA Patient Think Tank
Read Article -
Blog articles 22.01.24
From theory to therapy – MSD Policy Passport on Pharmaceutical Innovation (Guest blog)
Policy makers are in the driving seat. Their decisions play a key role in the creation and sustainability of Europe’s research and innovation ecosystem....
Read Article -
Blog articles 16.01.24
A new era for Precision Oncology: EFPIA’s vision for the future of cancer treatment in Europe beyond...
Envisioning a future where the potential of PO is not just theoretical but tangibly transformative necessitates aligning policy priorities and investments...
Read Article -
Blog articles 12.12.23
An Investment We Can't Ignore: Reflections on the Changing EU Pharmaceutical Landscape (Guest blog)
As Europe revises substantially its pharmaceutical legislative framework for the first time in 20 years, it remains critical that the region has the right...
Read Article